Current Research Interests
Dr. Salz’s research aims to improve the quality of care for cancer survivors, focusing primarily on late effects after cancer treatment. Her research addresses survivorship interventions, including needs assessments, clinical intervention development, and effectiveness testing. She currently leads an American Cancer Society-funded trial to test the implementation and effectiveness of a web-based intervention for personalizing the ongoing care of head and neck cancer survivors. Another area of her research addresses risk factors for cardiovascular late effects among lymphoma survivors to guide cardiovascular preventive care for this vulnerable population. She also is investigating trends in pain management among cancer survivors, focusing on trends in opioid and cannabis use.
View a full listing of Talya Salz’s journal articles.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Talya Salz discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures